SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gilead Science (GILD) Followers
GILD 122.74-0.4%Dec 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (286)5/7/1997 11:59:00 AM
From: Machaon   of 961
 
Henry, this doesn't seem to be a "big" loss for GILD, according to the the companies reaction.

I wonder if biotech companies get full reinbursement for their treatments, during these testing stages. If not, then the Federal government saves money, thru Medicare/Medicaid, via the FDA slowing down the approval process and keeping the biotechs in "testing" mode.

Lately, the FDA has been requesting additional info from biotechs. Could they have other motivations besides trying to assure safe and effective new drugs?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext